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Abstract
Background: Intermittent preventive treatment (IPT) has recently been accepted as an important component of
the malaria control strategy. Intermittent preventive treatment for children (IPTc) combined with timely treatment
of malaria related febrile illness at home to reduce parasite prevalence and malaria morbidity in children aged
between six and 60 months in a coastal community in Ghana. This paper reports persistence of reduced
parasitaemia two years into the intervention. The baseline and year-one-evaluation findings were published earlier.
Objective: The main objective in the second year was to demonstrate whether the two interventions would
further reduce parasite prevalence and malaria-related febrile illness in the study population.
Methods: This was an intervention study designed to compare baseline and evaluation findings without a
control group. The study combined home-based delivery of intermittent preventive treatment for children (IPTc)
aged 6 - 60 months and home treatment of suspected febrile malaria-related illness within 24 hours. All
children aged 6 - 60 months received home-based delivery of intermittent preventive treatment using
amodiaquine + artesunate, delivered at home by community assistants every four months (6 times in 24
months). Malaria parasite prevalence surveys were conducted before the first and after the third and sixth IPTc
to the children. The evaluation surveys were done four months after the third and sixth IPTc was given.
Results: Parasite prevalence which reduced from 25% to 3.0% at year-one evaluation had reduced further from 3%
to 1% at year-two-evaluation. At baseline, 13.8% of the children were febrile (axilary temperature of ≥37.5°C)
compared to 2.2% at year-one-evaluation while 2.1% were febrile at year-two-evaluation.
Conclusion: The year-two-evaluation result indicates that IPTc given three times in a year (every four months)
combined with timely treatment of febrile malaria illness, is effective to reduce malaria parasite prevalence in
children aged 6 to 60 months in the study community. This must give hope to malaria control programme
managers in sub-Saharan Africa where the burden of the disease is most debilitating.
Background
Malaria is estimated to cause between 300 and 500 mil-
lion clinical cases with about 700,000 to 1.6 million
deaths every year. About 94% of these deaths are
believed to occur in sub-Saharan Africa [1,2]. In 2006
malaria accounted for 37.5% of all outpatient clinic
visits, 36.0% of all admissions and about 33.4% of all
deaths in children under five years of age in Ghana [3].
In line with WHO recommendation and the observed
increasing treatment failure rate of chloroquine, the
Ghana National Malaria Control Programme, (GNMCP)
has adopted the use of artesunate and amodiaquine for
the treatment of uncomplicated malaria in the country
since January, 2005 [4,5].
Like elsewhere in Africa, malaria control in Ghana
relies on early diagnosis and prompt treatment of
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recognition and, in most cases, prompt treatment is
initiated [6-8]. IPTc delivered at home (community-
based approach) was found to achieve a higher coverage
compared to delivering at the clinic (facility-based
approached) [9]. This is an indication that a lot more
could be achieved through community involvement in
malaria control activities.
Malaria control through prompt and effective treat-
ment remains a challenge, especially in areas where
access to early effective treatment is a problem. It is in
these areas where IPT, especially IPTc could become an
important component of the malaria control strategy,
since it has been demonstrated that IPTi given with
childhood vaccinations reduced incidence of first epi-
sode of malaria and also reduced severe anaemia by
more than 50% during the first year of life [10-13]. It
was previously shown that when given three times in a
year this could reduce malaria parasite prevalence by
over 80% [8].
Rationale
The Ghana Health Service had aimed at treating 55% of
under-five febrile malaria cases within 24 hours of
symptom onset by 2007, as opposed to the Abuja target
of 60% by 2005, but three clear years after the expiration
date of 2007, this target is yet to be achieved. This study
was, therefore, designed to assess the potential of a
strategy of IPTc delivered at home and timely treatment
of febrile illness to reduce parasite prevalence and
malaria morbidity in the children-under 5 years as well
as contribute to achieving the target of getting 55% of
children under five into treatment within 24 hours. The
baseline and year-one-evaluation results were published
in 2009 [8]. This paper focuses on the year-two-evalua-
tion, making reference to the earlier findings to better
explain the current findings.
Objectives
This paper is to further demonstrate the feasibility of
controlling febrile malaria illness in the home through
combined interventions of intermittent preventive treat-
ment and timely febrile malaria illness management in
children aged 6 - 60 months in southern Ghana [8].
Methods
Study site
The study site was discussed in detail in the earlier publica-
tion [8]. In brief, the study was conducted at Shime sub-
district of the Keta district in the Volta region of Ghana,
where malaria accounts for over 40% outpatients’ clinic
attendance in the District (District Annual Report, 2006).
The study took place in an area with a population of 8,000.
Community entry activities, involving meetings and durbars
of chiefs and people in the study communities, were done
at the onset of the project. After gaining consent from care-
takers, children aged six to 60 months were enrolled into
the study and no caretaker refused participation [8].
Interventions
This was an intervention study designed to compare
baseline and evaluation findings without a control
group.
Intermittent preventive treatment for children (IPTc)
IPTc was delivered every four months beginning in July
2007 (July, November 2007 and March 2008) and was
evaluated in July, four months after the last round of
IPTc and just before the fourth round of IPTc [8]. Just
like the first year, IPTc was given three times (July,
November 2008 and March 2009) and the evaluation
took place four months after a total of six IPTc rounds
in 24 months. Children received 10 mg/kg body weight
of amodiaquine (AQ) and 4 mg/kg of artesunate (AS)
daily (given as a single dose) over three days. All treat-
ments were given under direct observation and children
were observed for five minutes after drug administration
to ensure that they retained the medication. Children
who vomited within five minutes after taking the medi-
cines received a repeated full dose. Children were fol-
lowed up on day 1, 2 and 3 after treatment (the day of
treatment was counted as Day 1) with adverse event
questionnaire [8].
Timely treatment of suspected febrile malaria in children
Any child with febrile illness suspected to have malaria
by the caretaker was reported to the community assis-
tants who then evaluated and treated those who met the
protocol criteria for suspected febrile malaria illness,
which was a child with axillary temperature of ≥ 37.5°C;
whose caretaker reported suspected febrile malaria
together with one or more of the following; headache,
hot body, weakness, loss of appetite, among others, with
no other overtly observed or reported condition was
treated with the full three-day course of artesunate and
amodiaquine [8].
Questionnaire survey
During IPTc rounds and prevalence surveys, a simple
questionnaire was administered to caretakers to record
febrile illnesses in the seven days prior to those events.
That is, caretakers whose children received IPTc at any
round and those who participated in the prevalence sur-
veys responded to the questions. Questions asked
included: Has your child been well in the past seven
days, including now? If no, what is/was wrong with
him/her? What was done for the child when you found
o u tt h a th e / s h ew a sn o tw e l l ?D u r i n gt h ep r e v a l e n c e
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bed net usage.
Sample size
This was an implementation research which aimed at
enrolling every child aged six to 60 months living in the
study area into the study with the consent of their care-
takers, mostly parents. However, for the prevalence sur-
v e y ,as a m p l es i z eo f1 7 4w a sn e e d e dt od e t e r m i n e
malaria parasite prevalence estimated at 20% in the
study population [14]. At the evaluations however, all
available participants at the time were examined. This
led to the examination of over 85% of children enrolled
into the study at both year-one and year-two evalua-
tions. Data were analysed to compare results from year-
one and year-two evaluation with reference to the base-
line results. All quantitative analyses were done using
Epi Info version 3.4.1.
Laboratory methods
A diagnosis of malaria infection was made with light
microscopy of thick and thin blood smears. The thick
and thin blood smears were stained with 3% Giemsa for
30 minutes. Parasite density was determined by counting
the number of asexual parasites per 200 white blood
cells, and calculated per μL assuming a white blood cell
count of 8,000 cells per μL. Sexual parasite count was
done per 1,000 white blood cells. A smear was declared
negative if examination of 100 thick-film fields did not
reveal the presence of asexual parasites. Quality control
was done by allowing a second microscopist to read a
random sample of 10% of all slides to confirm the
absence or presence of parasites. Haemoglobin concen-
tration was determined from finger pricks using a porta-
ble automated Hemocue
® photometer (Leo Diagnostics,
Sweden) at the field site [8].
Ethical review
The Institutional Review Board of the Noguchi Memor-
ial Institute for Medical Research, University of Ghana
and the Ethical Review Committee of WHO reviewed
and approved the study. Each mother/caretaker was
informed of the objectives, methods, anticipated benefits
and potential hazards of the study. Caretakers were also
informed that they were at liberty to withdraw their
children from the study at any time without penalty.
They were assured that all information collected during
this study would be kept confidential and that in any
resulting publication it would not be possible to link the
data to individuals in the study [8].
Results
This paper presents the two-year-evaluation of com-
bined IPTc and timely treatment febrile illnesses
(suspected clinical malaria). Most of the children
received IPTc six times in 24 months (on average 420
children were seen on each round, ranging between 413
and 433).
Parasite prevalence
Malaria parasite prevalence at year-one evaluation was
3.0% (10 out of 357), which further dropped significantly
to about 1.0% (3 out of 337) at year-two-evaluation, a
significant reduction of over 60.0%, p < 0.001, Fisher
exact test). This showed a point parasite prevalence
reduction of over 90.0% in 24 months (25.3% at baseline
to 1.0% at year-two-evaluation). There was a significant
relationship between febrile status and parasitaemia at
year-one-evaluation (p < 0.001, Fisher exact test) but
this was not the case at year-two evaluation. Two out of
the three parasite positive cases receive IPTc four times
and the remaining one received it twice. All the positive
infections were Plasmodium falciparum, the dominant
species in Ghana. Other clinical and parasitological find-
ings are presented in Table 1.
Anaemia
In this study, anaemia was defined as haemoglobin <10
g/dl and trend analysis showed a significant reduction
from baseline through to year-two evaluation (p =
0.003). Comparing the baseline level of 27.6% to year-
two evaluation level of 15.7% showed about 43.1%
reduction in anaemia cases in 24 months (Table 1).
There was a significant relationship between febrile sta-
tus and anaemia at year-one evaluation (P = 0.01 (Fisher
exact test)), but this was not the case at year-two-
evaluation.
D u r i n gt h ep r e v a l e n c es u r v e y s( b a s e l i n ea n de v a l u a -
tions) a number of febrile illnesses were reported for the
children within seven days prior to data collection
(Table 2). A trend analysis showed a significant reduc-
tion (p < 0.001). The point prevalence of fever cases
showed a reduction of over 85.0% when the baseline
level of 42% is compared to the year-two evaluation
level of 4.7%.
Intermittent preventive treatment for children (IPTc)
IPTc was delivered to children aged 6 to 60 months in
the study community six times (July and November
2007; March, July and November 2008 and March
2009). There have been marginal increases in the num-
ber of children at each subsequent treatment round
until the fourth, where it dropped marginally from 433
(IPTc3) to 415 (IPTc4), and then increased to 419
(IPTc5) and 421 (IPTc6). The decrease was largely due
to some children attaining the age of more than 60
months and were dropped out of the study. At the time
of year-two-evaluation, majority of the children have
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I P T cr o u n d sd u em a i n l yt oe i t h e rt h em o v e m e n to f
these children out of the study community at one point
or the other, or the entry points of participants, since
enrolment was prospective and any child who attained
the age of six month at any given time was enrolled.
However, the number of dropouts at each round was
too small for any meaningful comparative analysis to be
done on them. During each IPTc round, a number of
febrile illnesses were reported by caretakers within the
past seven days prior to treatment and trend analysis
showed significant reductions in reported fever as the
number of IPTc rounds increases (Table 3).
A number of febrile malaria-related illnesses were trea-
ted by community assistants in between IPTc rounds and
trend analysis showed no significant reduction in these
reported cases, when analysed from the first round. How-
ever, interviews with caretakers revealed that they were
sceptical about the ability of community assistants to
manage the febrile illnesses of their children until after
the second rounds of IPTc, so it was decided to perform
a second trend analysis starting from the second round
of IPTc, and this showed a significant reduction in the
reported febrile malaria/fever (<0.001) and headache
(0.021) reported as the IPTc rounds increased but not for
chills and rigors, and vomiting (Table 4).
There was virtually no serious adverse event reported
after drug administrations. However, some caretakers
reported that their children were weak for about two to
four hours after taking the medicines and these were;
five (1.21%) IPTc1, four (0.95%) IPTc2, seven (1.65%)
IPTc3, four (0.93%) IPTc4, five (1.13%) IPTc5 and 5
(1.11%) IPTc6. None of these cases warranted any medi-
cal intervention. A few caretakers also reported that
their children did eat very well after taking the drugs
but this could not be independently verified.
As this was at year-one evaluation, no caretaker had
lost a child in 12 months preceding the year-two evalua-
tion, indicating that, no caretaker had lost a child in the
twenty-four months of project implementation, except
two infants who died at birth and this was attributed to
t h ea b s e n c eo fam i d w i f ea tt h ec l i n i ca tt h et i m eo f
their birth.
Bed net usage
As expected, over 98% of the caretakers were mothers of
the children. Caretakers (98.0% at baseline and 100% at
both year-one and year-two evaluations) reported that
they and their families slept under bed nets the previous
night. Comparatively, insecticide-treated net usage has
increased marginally from 60.0% at year-one evaluation
to 63.0% at year-two evaluation. However, compared to
baseline (38.5%), there was a significant increase of
63.6% in the use of treated bed net in 24 months.
Discussion
This paper presents the two-year-evaluation of intermit-
tent preventive treatment for children (IPTc) combined
Table 1 Baseline, Year 1 and 2 Evaluation Characteristics, Clinical and Parasitological findings
Variables Baseline (N = 174) Evaluation Year 1 (N = 357) Evaluation Year 2 (N = 365)
Mean age in months (±std.) 30.5 (16.5) months 37.7 (15.8) months 38.19 (15.7) months
Sex (% of female) 52.3 47.0 50.1
Weight: Mean (±std.) 12.3 (3.5) 13.8 (3.5) 12.2 (3.3)
Haemoglobin < 10 g/dl (%) *** 48 (27.6) 60 (16.8) 53 (15.7)
Number (%) febrile ≥ 37.5°C ** 24 (13.8) 8 (2.2) 8 (2.1)
Parasite positive number (%) ** 44 (25.3%) 10 (3.0) 3 (1.0)
±std. = standard deviation.
** P = 0.000 and *** P = 0.003 (trend analysis).
Table 2 The distribution of febrile illnesses reported for children within the past seven days prior to the baseline and
evaluation prevalence surveys*
Variables Baseline (N = 174) Evaluation Year1 (N = 357) Evaluation Year 2 (N = 337)
Chills and Rigors ** 18 (10.3) 13 (3.6) 4 (1.2)
Convulsions 4 (2.3) 0 0
Diarrhoea ** 32 (18.4) 15 (4.2) 2 (1.2)
Fever/Malaria/Asra ** 73 (42.0) 27 (7.6) 16 (4.7)
Headache ** 58 (33.3) 18 (5.0) 6 (1.8)
Others (Cough, Rashes, Stomach ache etc.) *** 20 (11.5) 8 (2.2) 16 (4.7)
Vomiting ** 20 (11.5) 11 (3.1) 2 (0.6)
* Sorted in column 1 in alphabetical order.
** P < 0.001 and *** P = 0.011 (trend analysis).
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geting children aged 6 - 60 months old. The main find-
ing at year-two-evaluation was a further reduction of
about 66.6% (from 3.0% at year-one-evaluation to 1.0%
at year-two-evaluation) in malaria prevalence in the
study population compared to about 88.0% reduction
reported between baseline and year-one-evaluation
(25.0% at baseline and 3.0% at year-one-evaluation) [8].
Compared to baseline (25.0%), year-two-evaluation
shows a reduction of over 90.0% in parasite level in the
study population. Several studies in IPT intervention
measured clinical incidence rather than prevalence and
found between 20% and 86.0% reduction with strong
variations depending on transmission duration and
intensity, target population and intervals between treat-
ments [9-12,15-18].
Anaemia in the children, defined as haemoglobin
<10g/dl, further improved by 27.4% (from 16.8% at year-
one evaluation to 12.2% at year-two evaluation). Com-
pared to baseline, this was over 65.0% reduction in all
cause anaemia prevalence in the study population. This
compares well with a recent randomized trial in Tanza-
nia, which showed that IPT given to infants at the time
of childhood immunization reduced the incidence of the
f i r s te p i s o d eo fm a l a r i aa n da n a e m i ab ym o r et h a n
50.0% during the first year of life [11,12]. However, the
reduction in anaemia prevalence at year-two evaluation
compared to year-one evaluation was not as dramatic as
it was at year-one-evaluation compared to baseline. This
could be attributable to the low level of parasitaemia
observed after the year-one evaluation. Similar observa-
tion was also reported from The Gambia [19]. Thus, at
low prevalence, malaria may be contributing less to
anaemia in children aged 6-60 months.
Malaria-related morbidity in the study population,
expressed by the presence of fever and other malaria-
related signs and symptoms reported, has reduced as cap-
tured either during prevalence surveys or IPTc adminis-
tration. Timely treatment of febrile malaria cases in the
community did not follow any pattern. However, it could
be argued that the community assistants who were on
hand to deliver effective treatment in a timely fashion
have contributed to the marked reduction of parastaemia
seen during evaluation surveys. A community rando-
mized trial showed a slightly higher coverage in the com-
munity-based delivery arm compared to facility-based
arm [9]. This should encourage malaria control pro-
grammes to have confidence in community assistants to
deliver timely treatment and possibly IPTc to children at
community levels, once they are well trained by the pro-
gramme, coupled with reference treatment card for easy
and quick referencing when in doubt [8].
Findings reported here present a challenge to the
existing practice, especially in most sub-Saharan African
Table 3 The distribution of febrile illnesses reported for children within the past seven days prior to each drug
administration*
Febrile illness reported in
the past seven days prior
to drug administration
IPTC1 (N = 413) IPTC2 (N = 420) IPTC3 (N = 433) IPTC4 (N = 415) IPTC5 (N = 419) IPTC6 (N = 421)
Number (%) Number (%) Number (%) Number (%) Number (%) Number (%)
Fever/Malaria/Asra†** 64 (15.50) 43 (10.20) 11 (2.50) 8 (1.93) 9 (2.15) 7 (1.66)
Headache** 49 (11.90) 39 (9.30) 5 (1.20) 8 (1.93) 11 (2.62) 7 (1.66)
Vomiting** 25 (6.10) 11 (2.60) 1 (0.20) 1 (0.24) 5 (1.19) 2 (0.47)
Chills and Rigors*** 17 (4.10) 10 (2.40) 7 (1.60) 5 (1.20) 6 (1.43) 5 (1.19)
Others (Cough, Rashes,
Stomach ache etc.
7 (1.70) 5 (1.20) 9 (2.10) 12 (2.89) 8 (1.91) 10 (2.37)
Convulsions 5 (1.20) 0 0 0 0 0
Diarrhoea 5 (1.20) 1 (0.20) 3 (0.70) 2 (0.48) 2 (0.48) 1 (0.24)
*Sorted in column two in descending order to draw attention to the higher figures reported in that column.
** P = 0.000 and *** P = 0.002 (trend analysis).
Table 4 Febrile illnesses treated by community assistants in between IPTC rounds**
Febrile illness treated between TPTC rounds IPTC1-IPTC2
(N = 413)
IPTC2-IPTC3
(N = 420)
IPTC3-IPTC4
(N = 433)
IPTC4-IPTC5
(N = 415)
IPTC5-IPTC6
(N = 419)
Number (%) Number (%) Number (%) Number (%) Number (%)
Fever/Malaria/Asra 5 (1.21) 39 (9.28) 17 (3.93) 13 (3.13) 10 (2.39)
Headache 6 (1.45) 24 (5.71) 17 (3.93) 14 (3.37) 11 (2.62)
Chills and Rigors 4 (0.98) 12 (2.86) 9 (2.08) 11 (2.65) 7 (1.67)
Vomiting 0 4 (0.95) 3 (0.70) 8 (1.93) 4 (0.96)
**Sorted in column three in descending order to draw attention to the higher figures reported in that column.
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presumption without confirmation. As community inter-
ventions or access to treatment increases, this may lead
to fewer malaria infections, which may pose the danger
of over diagnosis and treatment with expensive drugs
for people who do not need them [8]. Control pro-
grammes should therefore invest in rapid diagnostic test
kits where microscopy is not possible. As reported by
Zikusooka et al [20], this may lead to cost savings
because artemisinin-based anti-malarial drugs are expen-
sive. Goodman et al [21] also make this point, as
rational use of anti-malarials will reduce the potential
for emergence of resistance.
The use of IPTc combined with timely home treat-
ment to control malaria was found to reduce malaria
prevalence in children aged six to 60 months [8].
Although this study cannot determine the contribution
of IPTc or timely home treatment to the protection
offered to the children because the two interventions
were delivered concurrently, the two together in this
study offered a major protection against malaria in chil-
dren, reducing prevalence from 25.0% at baseline to
1.0% at year-two evaluation (twenty-four months of
implementation). The question then is, at what point
should the provision of IPTc stop? What techniques or
methods could be used to mop-up the few parasites that
may continue to sustain transmission, because the vec-
tor mosquito is highly efficient in malaria transmission?
At this point, it may be recommended to reduce the
frequency of treatment from every four months to every
six months or providing treatment at the beginning of
each peak season (two peak seasons in southern Ghana).
Either way, the timing must be related to the major
peak season in the study area. At certain point it should
be necessary to treat the general population at least
once in a year to reduce the circulating parasites in the
population such that mosquitoes will have very little or
no parasite to transmit. Findings reported in this paper
indicates that, with consistent efforts, malaria could be
put under control such that it may no longer be a major
public health problem, especially in sub-Sahara Africa
where it is a threat to millions of people. Also, the study
shows that it is possible to train community assistants
to deliver IPTc together with home management of
malaria on timely basis with very little supervision.
However, additional training must be provided to enable
community assistance to use RDT in the community so
as to move away from presumptive treatment as malaria
incidence continues to go down in communities.
Study limitations
One major limitation of the study was that rapid diag-
nostic test (RDT) was not used to confirm the presence
of parasite before timely treatment was provided as a
result of the ethical consideration not to allow field
assistants to take blood from the children. Another
weakness of the study is that there was no control
group to compare the result so it was not possible to
attribute all the reduction in parasite prevalence to the
interventions. Also, the contribution of each of the
intervention to the reduction of parasite prevalence in
the study population was not measured. All these must
be taken into consideration when designing s similar
study in future.
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